{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:58:33Z","timestamp":1791907113475,"version":"4.3.4"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021081","name":"European Rare Kidney Disease Reference Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.phrs.2025.107714","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:35:48Z","timestamp":1744173348000},"page":"107714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulators"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-2289","authenticated-orcid":false,"given":"Emma Diletta","family":"Stea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0749-0172","authenticated-orcid":false,"given":"Mariateresa","family":"Pugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-7624","authenticated-orcid":false,"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-5458","authenticated-orcid":false,"given":"Monica","family":"Mazzucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3572-1524","authenticated-orcid":false,"given":"Luisa","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Annicchiarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3598-3142","authenticated-orcid":false,"given":"Alfredo","family":"Berardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3981-6325","authenticated-orcid":false,"given":"Stefano","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-0482","authenticated-orcid":false,"given":"Laura","family":"Bogliolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Chiandotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1155-4792","authenticated-orcid":false,"given":"Fabio","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8987-4596","authenticated-orcid":false,"given":"Silvia","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-7725","authenticated-orcid":false,"given":"Francesco","family":"Dentali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Facchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-6467","authenticated-orcid":false,"given":"Ennio\u00a0Giulio","family":"Favalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-0064","authenticated-orcid":false,"given":"Francesco","family":"Fiorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-8311","authenticated-orcid":false,"given":"Antonino","family":"Giarratano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6774-3771","authenticated-orcid":false,"given":"Claudia","family":"Laterza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4629-5281","authenticated-orcid":false,"given":"Francesco","family":"Macr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2738-8562","authenticated-orcid":false,"given":"Michelangelo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-3639","authenticated-orcid":false,"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8479-8379","authenticated-orcid":false,"given":"Andrea","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9954-3599","authenticated-orcid":false,"given":"Annalisa Maddalena","family":"Scopinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-6649","authenticated-orcid":false,"given":"Gian Domenico","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1618-7688","authenticated-orcid":false,"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1630-083X","authenticated-orcid":false,"given":"Beniamino","family":"Susi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-676X","authenticated-orcid":false,"given":"Antonio","family":"Torsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Vezzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8003-4626","authenticated-orcid":false,"given":"Luca","family":"Zanlari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-0911","authenticated-orcid":false,"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-7341","authenticated-orcid":false,"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.phrs.2025.107714_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejim.2024.02.015","article-title":"The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older","volume":"124","author":"Stea","year":"2024","journal-title":"Eur. J. Intern Med"},{"key":"10.1016\/j.phrs.2025.107714_bib3","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2147\/JMDH.S245620","article-title":"Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management","volume":"16","author":"Yerigeri","year":"2023","journal-title":"J. Multidiscip. Health"},{"key":"10.1016\/j.phrs.2025.107714_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/CLEP.S245642","article-title":"Epidemiology of atypical hemolytic uremic syndrome: a systematic literature review","volume":"12","author":"Yan","year":"2020","journal-title":"Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00431-015-2642-1","article-title":"Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network","volume":"175","author":"Ardissino","year":"2016","journal-title":"Eur. J. Pedia"},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.kint.2018.02.029","article-title":"Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2013.12.002","article-title":"Time to change the definition of hemolytic uremic syndrome","volume":"25","author":"Ardissino","year":"2014","journal-title":"Eur. J. Intern Med"},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107714_bib9","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13023-016-0537-5","article-title":"H.U.S.R.S.A.B. on behalf of the a, An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry","volume":"11","author":"Woodward","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/asheducation-2016.1.217","article-title":"Atypical hemolytic uremic syndrome","volume":"2016","author":"Afshar-Kharghan","year":"2016","journal-title":"Hematology"},{"issue":"8","key":"10.1016\/j.phrs.2025.107714_bib12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00467-018-4039-7","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome","volume":"34","author":"Formeck","year":"2019","journal-title":"Pedia Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12882-017-0727-y","article-title":"Differential diagnosis of thrombotic microangiopathy in nephrology","volume":"18","author":"Sakari Jokiranta","year":"2017","journal-title":"BMC Nephrol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12687-021-00520-9","article-title":"Rare disease care pathways in the EU: from odysseys and labyrinths towards highways","volume":"12","author":"Tumiene","year":"2021","journal-title":"J. Community Genet."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1186\/s12913-021-06926-y","article-title":"Health economic benefits through the use of diagnostic support systems and expert knowledge","volume":"21","author":"Willmen","year":"2021","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.phrs.2025.107714_bib16","unstructured":"State Regions Conference, Repertoire deed no. 121\/CSR, 2023. \u3008https:\/\/www.statoregioni.it\/it\/conferenza-stato-regioni\/sedute-2023\/seduta-del-24052023\/atti\/repertorio-atto-n-121csr\/\u3009. (Accessed 5 April 2024)."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1186\/s12913-023-09886-7","article-title":"Rare diseases: why is a rapid referral to an expert center so important?","volume":"23","author":"Willmen","year":"2023","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.phrs.2025.107714_bib18","unstructured":"L. Woodward, L. Burke, K. Shah, All aHUS alliance Global Action, UK, aHUS diagnosis process: patients\u2019 experience of specialist care and the diagnosis decision, 2022. \u3008https:\/\/www.ahusallianceaction.org\/wp-content\/uploads\/2022\/02\/aHUS-Diagnosis-Process-Patients-experience-specialist-care-diagnosis-decision-Report-3.pdf\u3009. (Accessed 29 February 2024)."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40620-016-0288-3","article-title":"Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment","volume":"30","author":"Walle","year":"2017","journal-title":"J. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11239-021-02431-5","article-title":"Neurological manifestations of thrombotic microangiopathy syndromes in adult patients","volume":"51","author":"Weil","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.19026","article-title":"A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies","volume":"203","author":"Scully","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"10364","key":"10.1016\/j.phrs.2025.107714_bib23","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0140-6736(22)01202-8","article-title":"Haemolytic uraemic syndrome","volume":"400","author":"Michael","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.phrs.2025.107714_bib24","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00467-023-06158-8","article-title":"Voice of a caregiver: call for action for multidisciplinary teams in the care for children with atypical hemolytic uremic syndrome","volume":"39","author":"Burke","year":"2023","journal-title":"Pedia Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107714_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2017.05.017","article-title":"Thrombotic microangiopathy: a multidisciplinary team approach","volume":"70","author":"Gordon","year":"2017","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/j.phrs.2025.107714_bib26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.12968\/hmed.2019.80.12.696","article-title":"Do multidisciplinary teams make a difference to the quality of medical care?","volume":"80","author":"Marsden","year":"2019","journal-title":"Br. J. Hosp. Med. (Lond. )"},{"issue":"11","key":"10.1016\/j.phrs.2025.107714_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206558","article-title":"Impact of a multidisciplinary team for the management of thrombotic microangiopathy","volume":"13","author":"Uriol Rivera","year":"2018","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.phrs.2025.107714_bib28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood.2022018833","article-title":"Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study","volume":"142","author":"Brocklebank","year":"2023","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.phrs.2025.107714_bib29","first-page":"458","article-title":"A case of adult atypical haemolytic uraemic syndrome related to anti-factor H autoantibodies successfully treated by plasma exchange, corticosteroids and rituximab","volume":"2","author":"Lionet","year":"2009","journal-title":"NDT"},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfac150","article-title":"Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan","volume":"38","author":"Ito","year":"2023","journal-title":"Nephrol. Dial. Transpl."},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12185-023-03630-x","article-title":"Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan","volume":"118","author":"Nishimura","year":"2023","journal-title":"Int. J. Hematol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107714_bib32","article-title":"Eculizumab versus ravulizumab for the treatment of atypical hemolytic uremic syndrome: a systematic review","volume":"15","author":"Shahid","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00467-020-04774-2","article-title":"The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab","volume":"36","author":"Tanaka","year":"2021","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.phrs.2025.107714_bib34","unstructured":"Italian Medicines Agency, Summary of product features - Ravulizumab, 2023. \u3008https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_003121_048059_RCP.pdf&sys=m0b1l3\u3009. (Accessed 8 April 2024)."},{"key":"10.1016\/j.phrs.2025.107714_bib35","unstructured":"Italian Medicines Agency, Reimbursement regime and price following new therapeutic indications of the medicinal product for human use - Soliris, 2014. \u3008https:\/\/www.aifa.gov.it\/documents\/20142\/241028\/Determina_SOLIRIS_aSEU.pdf\u3009. (Accessed 8 April 2024)."},{"key":"10.1016\/j.phrs.2025.107714_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/295323","article-title":"Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome","author":"Tsai","year":"2014","journal-title":"Adv. Hematol. 2014"},{"issue":"8","key":"10.1016\/j.phrs.2025.107714_bib37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic uremic syndrome in pregnancy and postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107714_bib38","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.kint.2024.09.012","article-title":"Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum","volume":"106","author":"Kavanagh","year":"2024","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/ckj\/sfy066","article-title":"Atypical hemolytic uremic syndrome: a syndrome in need of clarity","volume":"12","author":"Berger","year":"2019","journal-title":"Clin. Kidney J."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"H.U.S. International, An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pedia Nephrol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107714_bib41","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/ndt\/gft198","article-title":"The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome","volume":"28","author":"Szil\u00e1gyi","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.phrs.2025.107714_bib42","first-page":"2794060","article-title":"Late onset cobalamin disorder and hemolytic uremic syndrome: a rare cause of nephrotic syndrome","volume":"2017","author":"Ardissino","year":"2017","journal-title":"Case Rep. Pedia"},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/1744-9987.12535","article-title":"At the cross section of thrombotic microangiopathy and atypical hemolytic uremic syndrome: a narrative review of differential diagnostics and a problematization of nomenclature","volume":"21","author":"\u00c5kesson","year":"2017","journal-title":"Ther. Apher. Dial."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib44","first-page":"74","article-title":"Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease [in Italian]","volume":"34","author":"Visconti","year":"2017","journal-title":"G Ital. Nefrol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107714_bib45","article-title":"Ischemic cerebrovascular complications with initial presentation of genetic atypical hemolytic uremic syndrome","volume":"32","author":"Sokola","year":"2023","journal-title":"J. Stroke Cereb. Dis."},{"issue":"10095","key":"10.1016\/j.phrs.2025.107714_bib46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.rdc.2018.06.010","article-title":"Thrombotic microangiopathies with rheumatologic involvement","volume":"44","author":"Babar","year":"2018","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"11","key":"10.1016\/j.phrs.2025.107714_bib48","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/art.40219","article-title":"The evolving landscape for complement therapeutics in rheumatic and autoimmune diseases","volume":"69","author":"Thurman","year":"2017","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.phrs.2025.107714_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.05.007","article-title":"The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review","volume":"92","author":"Cervera","year":"2018","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib50","first-page":"503","article-title":"Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome","volume":"33","author":"Hernandez-Molina","year":"2015","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.phrs.2025.107714_bib51","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fimmu.2018.01008","article-title":"Renal involvement in antiphospholipid syndrome","volume":"9","author":"Turrent-Carriles","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40620-018-0517-z","article-title":"Eculizumab in pregnancy: a narrative overview","volume":"32","author":"Sarno","year":"2019","journal-title":"J. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib54","article-title":"Complement-driven hemolytic uremic syndrome","volume":"98","author":"Leon","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"4, ement","key":"10.1016\/j.phrs.2025.107714_bib55","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2025.107714_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860689","article-title":"Ex vivo test for measuring complement attack on endothelial cells: from research to bedside","volume":"13","author":"Meuleman","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.06440616","article-title":"Pathogenic variants in complement genes and risk of atypical hemolytic uremic syndrome relapse after eculizumab discontinuation","volume":"12","author":"Fakhouri","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107714_bib58","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-3503","article-title":"Case report: benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome","volume":"135","author":"Cullinan","year":"2015","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.phrs.2025.107714_bib59","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2025.107714_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.phrs.2025.107714_bib61","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.transproceed.2023.02.066","article-title":"Kidney transplant outcomes in patients with atypical hemolytic uremic syndrome","volume":"55","author":"Balwani","year":"2023","journal-title":"Transpl. Proc."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.phrs.2025.107714_bib63","article-title":"Outcomes of renal transplant in patients with anti-complement factor H antibody-associated hemolytic uremic syndrome","volume":"18","author":"Khandelwal","year":"2014","journal-title":"Pedia Transpl."},{"key":"10.1016\/j.phrs.2025.107714_bib64","article-title":"Case series of 3 patients diagnosed with atypical hemolytic uremic syndrome successfully treated with steroids, plasmapheresis, and rituximab","volume":"5","author":"Patterson","year":"2018","journal-title":"CJKHD"},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib65","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.phrs.2025.107714_bib66","doi-asserted-by":"crossref","first-page":"1088031","DOI":"10.3389\/fphar.2022.1088031","article-title":"Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli","year":"2022","journal-title":"Front Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/srep27915","article-title":"Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling","volume":"6","author":"Rodrigues-Diez","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2025.107714_bib68","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys","volume":"5","author":"Sartelet","year":"2005","journal-title":"Am. J. Transpl."},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib69","first-page":"151","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transpl. Cell Ther."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib70","doi-asserted-by":"crossref","first-page":"1000229","DOI":"10.4172\/2090-7214.1000229","article-title":"Atypical hemolytic uremic syndrome in tertiary hospital, Pakistan","volume":"13","author":"Badruddin","year":"2016","journal-title":"Clin. Mother Child Health"},{"issue":"5","key":"10.1016\/j.phrs.2025.107714_bib71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2025.107714_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2021.06.048","article-title":"Bloody diarrhea and Shiga Toxin\u2013producing Escherichia coli hemolytic uremic syndrome in children: data from the ItalKid-HUS Network","volume":"237","author":"Ardissino","year":"2021","journal-title":"J. Pedia"},{"key":"10.1016\/j.phrs.2025.107714_bib73","series-title":"Hemolytic uremic syndrome","first-page":"NBK556038","author":"Bhandari","year":"2024"},{"issue":"12","key":"10.1016\/j.phrs.2025.107714_bib74","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00467-010-1606-y","article-title":"Neurological involvement in a child with atypical hemolytic uremic syndrome","volume":"25","author":"Koehl","year":"2010","journal-title":"Pedia Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107714_bib75","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/ijlh.13682","article-title":"2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions","volume":"43","author":"Zini","year":"2021","journal-title":"Int. J. Lab Hematol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib76","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200177","article-title":"Low efficacy of vaccination against serogroup B meningococci in patients with atypical hemolytic uremic syndrome","volume":"40","author":"M\u00fclling","year":"2020","journal-title":"Biosci. Rep."},{"issue":"27","key":"10.1016\/j.phrs.2025.107714_bib77","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib78","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/QCO.0000000000000279","article-title":"Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis","volume":"29","author":"Benamu","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.phrs.2025.107714_bib79","unstructured":"European Medicines Agency, Summary of product characteristics of eculizumab, 2023. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/soliris-epar-product-information_en.pdf\u3009. (Accessed 28 February 2024)."},{"key":"10.1016\/j.phrs.2025.107714_bib80","unstructured":"European Medicines Agency, Summary of product characteristics of ravulizumab, 2023. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ultomiris-epar-product-information_en.pdf\u3009. (Accessed 28 February 2024)."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib81","doi-asserted-by":"crossref","first-page":"129","DOI":"10.24953\/turkjped.2022.190","article-title":"Meningococcemia in a vaccinated child receiving eculizumab and review of the literature","volume":"65","author":"\u00dc\u00e7karde\u015f","year":"2023","journal-title":"Turk. J. Pedia"},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib82","first-page":"819","article-title":"Meningococcal sepsis complicating eculizumab treatment despite prior vaccination","volume":"13","author":"Struijk","year":"2013","journal-title":"AJT"},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib83","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0000000000002075","article-title":"Risk of disseminated gonococcal infections with terminal complement blockade","volume":"44","author":"Graciaa","year":"2022","journal-title":"J. Pedia Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib84","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chest.2017.03.055","article-title":"Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome","volume":"152","author":"Azoulay","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.phrs.2025.107714_bib85","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00467-016-3569-0","article-title":"Long-term health-related quality of life and psychological adjustment in children after haemolytic-uraemic syndrome","volume":"32","author":"Werner","year":"2017","journal-title":"Pedia Nephrol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107714_bib86","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ckj\/sfab005","article-title":"Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes","volume":"14","author":"Ariceta","year":"2021","journal-title":"Clin. Kidney J."},{"issue":"11","key":"10.1016\/j.phrs.2025.107714_bib87","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003573","article-title":"A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)","volume":"3","author":"Rathbone","year":"2013","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib88","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/jcm8030407","article-title":"The extended use of eculizumab in pregnancy and complement activation-associated diseases affecting maternal, fetal and neonatal kidneys-the future is now?","volume":"8","author":"Stefanovic","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12882-020-02190-0","article-title":"Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis","volume":"22","author":"G\u00e4ckler","year":"2021","journal-title":"BMC Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107714_bib90","first-page":"221","article-title":"Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach","volume":"18","author":"Laurence","year":"2020","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107714_bib91","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N. Eng. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40272-022-00555-6","article-title":"Pharmacological management of atypical hemolytic uremic syndrome in pediatric patients: current and future","volume":"25","author":"Gurevich","year":"2023","journal-title":"Paediatr. Drugs"},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib93","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1681\/ASN.2019050515","article-title":"CFHR gene variations provide insights in the pathogenesis of the kidney diseases atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"31","author":"Zipfel","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107714_bib94","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/bloodadvances.2020003175","article-title":"Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome","volume":"5","author":"Chaturvedi","year":"2021","journal-title":"Blood Adv."},{"issue":"9","key":"10.1016\/j.phrs.2025.107714_bib95","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jth.12615","article-title":"Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome","volume":"12","author":"Cugno","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib96","doi-asserted-by":"crossref","first-page":"2231264","DOI":"10.1080\/0886022X.2023.2231264","article-title":"New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses","volume":"45","author":"Tang","year":"2023","journal-title":"Ren. Fail"},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib97","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.ajkd.2015.04.010","article-title":"Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update","volume":"66","author":"Ardissino","year":"2015","journal-title":"AJKD"},{"issue":"18","key":"10.1016\/j.phrs.2025.107714_bib98","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood.2020009280","article-title":"Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study","volume":"137","author":"Fakhouri","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2025.107714_bib99","first-page":"310","article-title":"Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome","volume":"10","author":"Macia","year":"2017","journal-title":"Clin. Kidney J."},{"issue":"17","key":"10.1016\/j.phrs.2025.107714_bib100","first-page":"2447","article-title":"Activities of clinical expertise and research in a rare disease referral centre: a place for telemedicine beyond the covid-19 pandemic?","volume":"11","author":"Ducrocq","year":"2023","journal-title":"Healthc. (Basel)"},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib101","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s13023-022-02527-y","article-title":"Rare disease education in Europe and beyond: time to act","volume":"17","author":"Tumiene","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.phrs.2025.107714_bib102","unstructured":"State-Regions Conference, Repertoire deed no. 121\/CSR, 2023. \u3008https:\/\/www.statoregioni.it\/it\/conferenza-stato-regioni\/sedute-2023\/seduta-del-24052023\/atti\/repertorio-atto-n-121csr\/\u3009. (Accessed February 26 2024)."},{"issue":"2","key":"10.1016\/j.phrs.2025.107714_bib103","doi-asserted-by":"crossref","first-page":"ii40","DOI":"10.1136\/bmjqs-2013-001884","article-title":"Use of health information technology to reduce diagnostic errors","volume":"22","author":"El-Kareh","year":"2013","journal-title":"BMJ Qual. Saf."},{"issue":"1","key":"10.1016\/j.phrs.2025.107714_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000512629","article-title":"Lessons learnt during the COVID-19 pandemic: for patients with end-stage renal disease, we should prioritize home-based treatment and telemedicine","volume":"46","author":"Brunori","year":"2021","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.phrs.2025.107714_bib105","unstructured":"Italian Ministry of Health, National Plan for Rare Diseases 2023\u20132026, 2022. https:\/\/www.malattierare.gov.it\/normativa\/download\/792\/PIANONAZIONALEMALATTIERARE2023(1).pdf. (Accessed 28 February 2024)."},{"key":"10.1016\/j.phrs.2025.107714_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.940010","article-title":"Real-world use of orphan medicinal products (OMPs) in rare disease (RD) patients: A population-based registry study","volume":"13","author":"Mazzucato","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:45:47Z","timestamp":1762353947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825001392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":106,"alternative-id":["S1043661825001392"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107714","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulators","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107714"}}